Condensed Consolidated Statements of Changes in Mezzanine Equity and Stockholder's Deficit - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Series B Convertible Preferred Stock	Redeemable Common Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		0
Beginning balance at Dec. 31, 2022		$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)		30,000
Issuance of stock		$ 3,867
Preferred stock issuance costs		(253)
Accretion on convertible preferred stock		$ 653
Ending balance (in shares) at Mar. 31, 2023		30,000
Ending balance at Mar. 31, 2023		$ 4,267
Beginning balance (in shares) at Dec. 31, 2022					8,242,009
Beginning balance at Dec. 31, 2022	$ (10,635)				$ 1	$ 212,122	$ (222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(653)					(653)
Issuance of warrants	43					43
Issuance of common stock upon exercise of stock options (in Shares)					18,054
Issuance of common stock upon exercise of stock options	55					55
Issuance of common stock for restricted stock units vesting (in shares)					115,257
Issuance of common stock for employee stock purchase plans (in shares)					15,104
Issuance of common stock for employee stock purchase plan	101					101
Stock-based compensation	2,789					2,789
Net income (loss)	(11,867)						(11,867)
Ending balance (in shares) at Mar. 31, 2023					8,390,424
Ending balance at Mar. 31, 2023	(20,167)				$ 1	214,457	(234,625)
Beginning balance (in shares) at Dec. 31, 2022		0
Beginning balance at Dec. 31, 2022		$ 0
Ending balance (in shares) at Sep. 30, 2023		30,000
Ending balance at Sep. 30, 2023		$ 6,912
Beginning balance (in shares) at Dec. 31, 2022					8,242,009
Beginning balance at Dec. 31, 2022	(10,635)				$ 1	212,122	(222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(25,975)
Ending balance (in shares) at Sep. 30, 2023					8,563,301
Ending balance at Sep. 30, 2023	(31,952)				$ 1	216,780	(248,733)
Beginning balance (in shares) at Mar. 31, 2023		30,000
Beginning balance at Mar. 31, 2023		$ 4,267
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 1,326
Ending balance (in shares) at Jun. 30, 2023		30,000
Ending balance at Jun. 30, 2023		$ 5,593
Beginning balance (in shares) at Mar. 31, 2023					8,390,424
Beginning balance at Mar. 31, 2023	(20,167)				$ 1	214,457	(234,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(1,326)					(1,326)
Issuance of common stock for restricted stock units vesting (in shares)					51,259
Stock-based compensation	2,644					2,644
Net income (loss)	(8,467)						(8,467)
Ending balance (in shares) at Jun. 30, 2023					8,441,683
Ending balance at Jun. 30, 2023	(27,316)				$ 1	215,775	(243,092)
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 1,319
Ending balance (in shares) at Sep. 30, 2023		30,000
Ending balance at Sep. 30, 2023		$ 6,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(1,319)					(1,319)
Issuance of common stock for restricted stock units vesting (in shares)					93,525
Issuance of common stock for employee stock purchase plans (in shares)					28,093
Issuance of common stock for employee stock purchase plan	114					114
Stock-based compensation	2,210					2,210
Net income (loss)	(5,641)						(5,641)
Ending balance (in shares) at Sep. 30, 2023					8,563,301
Ending balance at Sep. 30, 2023	(31,952)				$ 1	216,780	(248,733)
Beginning balance (in shares) at Dec. 31, 2023		28,628	0	0
Beginning balance at Dec. 31, 2023	7,855	$ 7,855	$ 0	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)		0	9,250
Issuance of stock		$ 0	$ 2,394
Preferred stock issuance costs		0	(102)
Accretion on convertible preferred stock and redeemable common stock		$ 1,212	$ 116
Conversion of preferred stock (in shares)		(1,178)
Conversion of preferred stock		$ (332)
Ending balance (in shares) at Mar. 31, 2024		27,450	9,250	0
Ending balance at Mar. 31, 2024		$ 8,735	$ 2,408	$ 0
Beginning balance (in shares) at Dec. 31, 2023					8,797,456
Beginning balance at Dec. 31, 2023	(37,531)				$ 1	218,127	(255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance costs	0					0
Accretion on convertible preferred stock	$ (1,328)					$ (1,328)
Conversion of preferred stock	332,000				171,719	332,000
Issuance of common stock for restricted stock units vesting (in shares)					22,437
Issuance of common stock for employee stock purchase plans (in shares)					22,791
Issuance of common stock for employee stock purchase plan	$ 92					$ 92
Stock-based compensation	2,227					2,227
Net income (loss)	3,274						3,274
Ending balance (in shares) at Mar. 31, 2024					9,014,403
Ending balance at Mar. 31, 2024	(32,934)				$ 1	219,450	(252,385)
Beginning balance (in shares) at Dec. 31, 2023		28,628	0	0
Beginning balance at Dec. 31, 2023	7,855	$ 7,855	$ 0	$ 0
Ending balance (in shares) at Sep. 30, 2024		11,479	9,250	750,000
Ending balance at Sep. 30, 2024	12,069	$ 4,652	$ 3,104	$ 4,313
Beginning balance (in shares) at Dec. 31, 2023					8,797,456
Beginning balance at Dec. 31, 2023	(37,531)				$ 1	218,127	(255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(3,484)
Ending balance (in shares) at Sep. 30, 2024					15,393,881
Ending balance at Sep. 30, 2024	(21,459)				$ 2	237,682	(259,143)
Beginning balance (in shares) at Mar. 31, 2024		27,450	9,250	0
Beginning balance at Mar. 31, 2024		$ 8,735	$ 2,408	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock and redeemable common stock		$ 1,187	$ 348
Conversion of preferred stock (in shares)		(250)
Conversion of preferred stock		$ (83)
Ending balance (in shares) at Jun. 30, 2024		27,200	9,250	0
Ending balance at Jun. 30, 2024		$ 9,839	$ 2,756	$ 0
Beginning balance (in shares) at Mar. 31, 2024					9,014,403
Beginning balance at Mar. 31, 2024	(32,934)				$ 1	219,450	(252,385)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	$ (1,535)					$ (1,535)
Conversion of preferred stock	83,000				36,443	83,000
Issuance of common stock for restricted stock units vesting (in shares)					48,693
Stock-based compensation	$ 2,104					$ 2,104
Net income (loss)	(1,147)						(1,147)
Ending balance (in shares) at Jun. 30, 2024					9,099,539
Ending balance at Jun. 30, 2024	(33,429)				$ 1	220,102	(253,532)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of stock (in shares)				750,000
Issuance of stock				$ 4,308
Accretion on convertible preferred stock and redeemable common stock		$ 867	$ 348	$ 5
Conversion of preferred stock (in shares)		(15,721)
Conversion of preferred stock		$ (6,054)
Ending balance (in shares) at Sep. 30, 2024		11,479	9,250	750,000
Ending balance at Sep. 30, 2024	12,069	$ 4,652	$ 3,104	$ 4,313
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance costs	(2,141)					(2,141)
Accretion on convertible preferred stock	(1,215)					(1,215)
Accretion on redeemable common stock	(5)					(5)
Issuance of warrants	382					382
RSU to RSA conversion (in shares)					387,309
Issuance of common stock upon exercise of stock options (in Shares)					4,018
Issuance of common stock upon exercise of stock options	$ 17					$ 17
Conversion of preferred stock	6,054,000				2,291,686	6,054,000
Issuance of common stock related to offering (in shares)					3,135,136
Issuance of common stock related to offering (Note 7)	$ 11,601				$ 1	$ 11,600
Issuance of common stock for restricted stock units vesting (in shares)					439,659
Issuance of common stock for employee stock purchase plans (in shares)					36,534
Issuance of common stock for employee stock purchase plan	129					129
Stock-based compensation	2,759					2,759
Net income (loss)	(5,611)						(5,611)
Ending balance (in shares) at Sep. 30, 2024					15,393,881
Ending balance at Sep. 30, 2024	$ (21,459)				$ 2	$ 237,682	$ (259,143)